AstraZeneca Leads FTSE 100 Winners as Pharma Defies Market Rout

AstraZeneca topped FTSE 100 performers despite Friday's 2% market slump, with the £237bn pharma giant leading a small group of defensive gainers as political risk weighed on cyclicals.

AstraZeneca topped FTSE 100 performers despite Friday's 2% market slump, with the £237bn pharma giant leading a small group of defensive gainers as political risk weighed on cyclicals.